Cure8 research brief
Researchers and clinicians looking for blood- or tissue-based molecular tests for IBD may find these integrated transcriptomic analyses useful because they identify candidate diagnostic biomarkers and highlight shared inflammatory signals across GI diseases.
Researchers working on IBD biomarkers, clinical researchers designing diagnostic tests, and clinicians interested in molecular diagnostics or the biology of intestinal inflammation.
The study combined multiple public gene-expression datasets (totaling thousands of samples) and applied machine-learning methods (random forest and LASSO) plus ROC analysis to find transcripts with diagnostic potential for IBD.
Several genes emerged repeatedly across analyses and external cohorts, and at least one complement-related gene was consistently upregulated and showed AUCs >0.7 in many cohorts.
The authors also report that some of the same transcriptomic signals are elevated in autoimmune gastritis, eosinophilic esophagitis, and colorectal cancer, which suggests limited disease specificity for those markers and points to shared inflammatory pathways such as complement activation.
This classification and note are grounded in the PubMed abstract. The abstract reports integration of multiple GEO datasets and machine-learning selection of DEGs with ROC validation across cohorts; it does not itself provide full validation details or clinical assay readiness.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The review highlights how microbial metabolites, epigenetic regulation, and mitochondrial metabolism interact to shape inflammation and barrier function in IBD. Understanding these links could help identify new...
Shows which IBD comorbidities may be driven in part by shared inherited genetic risk and which likely reflect non-genetic factors, information that could shape future risk stratification and screening approaches for...
Links between IBD genetic risk and specific adult tissue lesion contexts help researchers understand which cell types and tissue programs may mediate inherited susceptibility. That can guide future biomarker and...
